L

Leo International Precision Health
SBE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€11.55M
EV
-
Shares Outstanding
550.00K
Beta
-
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2024E
-
P/Revenue 2024E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2024E
-
Net Profit Margin 2024E
-
ROE 2024E
-
ROCE 2023
-

Dividends

DPS 2024E
-
Payout Ratio 2024E
-
Div. Yield 2024E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Leo International Precision Health AG

gainify

L

Leo International Precision Health AG

SBE

Leo International Precision Health AG engages in the healthcare technology business in Germany. The company is based in Garching bei München, Germany.

Sector

Industry

CEO

Lo, Joshua

Employees

IPO Date

Headquarters

Dieselstrasse 21, Garching bei München, Bavaria, 85748, Germany

📊 Stock Price & Performance

Review the recent SBE stock performance trends:Past 3 Months: The stock has +77.75%. Last updated: December 31, 2025 at 11:43 PM Eastern Time

💰 Financial Metrics & Reports

The current Leo International Precision Health (SBE) market capitalization is approximately €11.55M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Leo International Precision Health's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:43 PM Eastern Time

In the most recently reported quarter, Leo International Precision Health (SBE) generated €4.28K in revenue. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: May 27, 2025 at 1:49 AM Eastern Time

In the most recently reported fiscal year, Leo International Precision Health (SBE) generated net income of €-0.12M, compared with €-71.56K in the prior fiscal year, representing a -70.75% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: May 27, 2025 at 1:49 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Leo International Precision Health (SBE) revenue was €4.28K. Earnings per share (EPS) for the quarter were €-0.08. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: May 27, 2025 at 1:49 AM Eastern Time

Leo International Precision Health (SBE) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: May 27, 2025 at 1:49 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Leo International Precision Health (SBE) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated:

Like other publicly traded stocks, Leo International Precision Health (SBE) shares are bought and sold on stock exchanges such as DB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Leo International Precision Health (SBE) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add SBE to your watchlist.

Leo International Precision Health trades under the ticker symbol SBE on the DB stock exchange. The ticker SBE is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.